Daphna Laifenfeld

Daphna Laifenfeld is a prominent professional in the fields of personalized medicine, diagnostics, and medical device strategies. As Co-founder and Chief Scientific Officer at Genetika+ since October 2017 and Founder, President, and CEO of Spacegate LLC since January 2011, Daphna has developed regulatory, clinical, and go-to-market roadmaps. Daphna's experience includes serving as Chief Scientific Officer at Ibex Medical Analytics and Head of Personalized Medicine & Diagnostics at Teva Pharmaceuticals. In addition, Daphna has held various mentorship roles, including at ScienceAbroad and T2MED Technion. Daphna holds a PhD in Medical Science/Molecular Biology from the Technion - Israel Institute of Technology, and has pursued further education at Harvard Business School and Boston University.